Investor

Investor

Select language version:

Dannebro   Union Jack

Calender

Events and financial calender

Speaker

Announcements and financial reports

Share

Share and investor portal

Legal

Legal documents

Paper

Commissioned research

FOM Technologies
listed on Nasdaq First North

Welcome to the investor information site
of FOM Technologies.

On this site, we have gathered all information, relevant for current and potential investors. We hope that you’d like to join our growth journey!

 

Subsidiary

MLMC Therapeutics is a subsidary of FOM Technologies.

Our mission is to develop production processes for oral drugs. At present the company has no operational activity.

 

FOM Technologies owns a 51% stake in MLMC Therapeutics ApS.